In a cross-sectional study of 240 patients with chronic kidney disease, higher serum BDNF levels and a ...

Limited (“ HUTCHMED ” or the “Company”) (Nasdaq/AIM:HCM; HKEX:13) today announces that further to its announcement on September 3, 2026 and following the completion of customary closing conditions ...

A federal judge in Mexico City ordered former Chihuahua Attorney General César Jáuregui to remain in custody after federal prosecutors formally charged him of treason in a case involving the alleged ...

Alexion, AstraZeneca Rare Disease’s Ultomiris (ravulizumab) has been approved in the United States to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of disease ...

A chemically complex chilli-pepper extract reduced proliferation, inflammation and oxidative-stress markers in a DEN-induced ...

Dublin, Oct. (GLOBE NEWSWIRE) -- "Acute Kidney Injury - Pipeline Insight, 2026" has been added to ResearchAndMarkets.com's offering. The report delivers a comprehensive analysis of the Acute Kidney ...

Researchers engineered hybrid strontium sulfite nanoparticle-modified lipid nanoparticles to deliver p53 mRNA, producing ...

The US FDA has approved GSK’s Hibsago for chronic hepatitis B, with 19% of trial participants achieving a functional cure.

UK consumer price inflation was hotter than expected, according to numbers on Wednesday. The Office for National Statistics said the annual consumer price inflation rate accelerated to 3.5% in ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...

The Goa Shipyard Limited (GSL) has released the Recruitment 2026 notification for 3 Consultant (Infrastructure Finance) posts. The last date to submit the offline application is 05 November 2026.

Alexion, AstraZeneca Rare Disease's Ultomiris (ravulizumab) has been approved in the US to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression ...